Commercial · PA
Highmark
Highmark publishes coverage policies for 4 of the 4 sleep apnea treatments we track. Each is linked to its source document below.
By treatment
CPAP and PAP therapy
Policy publishedPolicy number — E-20-038
Effective — 2023-10-01
Prior authorisation — Not stated in the policy we found
Try another treatment first — Not stated
Oral appliance therapy
Policy publishedPolicy number — E-20-038
Effective — 2023-10-01
Prior authorisation — Not stated in the policy we found
Try another treatment first — Yes
- The policy requires CPAP to have failed or be contraindicated before an intraoral appliance is covered.
Hypoglossal nerve stimulation
Policy publishedPolicy number — S-280-003
Prior authorisation — Not stated in the policy we found
Try another treatment first — Yes
- Published HNS criteria require prior PAP failure or intolerance.
Tirzepatide (Zepbound) for OSA
Policy publishedPolicy number — J-1388-013
Effective — 2025-08-26
Prior authorisation — Required
Try another treatment first — Yes
- For the published Delaware commercial OSA pathway, the member must be compliant with PAP or have failed/cannot use PAP and then be adherent to a custom oral appliance, along with other policy requirements.
Last verified 2026-08-15. We record structured facts and link the source; we do not reproduce policy text. The document itself governs.
If you're denied
Highmark publishes its own appeal instructions. Start there, and note the deadline on your denial letter.
Your specific plan may differ from Highmark's general policy, particularly if your coverage is through an employer. Policies are revised without notice. Nothing here is a guarantee of coverage or a substitute for confirming with your plan.